Literature DB >> 30397054

Genetic Correlation of Antibiotic Susceptibility and Resistance Genotyping for the Mycobacterium abscessus Group.

Huiwen Zheng1, Dongxin Liu2, Jie Lu1, Yuanyuan Song2, Shengfen Wang2, Yanlin Zhao3, Xin Ni4.   

Abstract

Treatment efficacy of Mycobacterium abscessus infections depends on bacterial genotype. Here, the relationship between genotype, as determined by sequence analysis, and antibiotic resistance phenotype was analyzed. The results demonstrate that M. abscessus genotype characteristics, including erm(41) sequevar and mutations of rrl and rrs, are predictive of clarithromycin and amikacin resistance.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Mycobacterium abscessuszzm321990; genotype; resistance

Mesh：

Substances：

Year:  2018        PMID： 30397054      PMCID： PMC6325201          DOI： 10.1128/AAC.01523-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.

Authors:  Sylvaine Bastian; Nicolas Veziris; Anne-Laure Roux; Florence Brossier; Jean-Louis Gaillard; Vincent Jarlier; Emmanuelle Cambau
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

3.  Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease.

Authors:  Julie Jarand; Adrah Levin; Lening Zhang; Gwen Huitt; John D Mitchell; Charles L Daley
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

4.  A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.

Authors:  Kevin A Nash; Barbara A Brown-Elliott; Richard J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

5.  Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients.

Authors:  D E Griffith; W M Girard; R J Wallace
Journal:  Am Rev Respir Dis       Date:  1993-05

6.  Comparison of six simple methods for extracting ribosomal and mitochondrial DNA from Toxocara and Toxascaris nematodes.

Authors:  F Mikaeili; E B Kia; M Sharbatkhori; M Sharifdini; N Jalalizand; Z Heidari; Z Zarei; C R Stensvold; H Mirhendi
Journal:  Exp Parasitol       Date:  2013-03-13       Impact factor: 2.011

7.  Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41).

Authors:  Florian P Maurer; Vera Rüegger; Claudia Ritter; Guido V Bloemberg; Erik C Böttger
Journal:  J Antimicrob Chemother       Date:  2012-07-24       Impact factor: 5.790

8.  Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar.

Authors:  Faiza Mougari; Rishma Amarsy; Nicolas Veziris; Sylvaine Bastian; Florence Brossier; Béatrice Berçot; Laurent Raskine; Emmanuelle Cambau
Journal:  J Antimicrob Chemother       Date:  2016-05-04       Impact factor: 5.790

9.  Relationship between Antibiotic Susceptibility and Genotype in Mycobacterium abscessus Clinical Isolates.

Authors:  Bing Li; Shiyi Yang; Haiqing Chu; Zhemin Zhang; Weijia Liu; Liulin Luo; Wei Ma; Xiaogang Xu
Journal:  Front Microbiol       Date:  2017-09-14       Impact factor: 5.640

10.  The drug resistance profile of Mycobacterium abscessus group strains from Korea.

Authors:  Seung Heon Lee; Hee Kyung Yoo; Seol Hee Kim; Won-Jung Koh; Chang Ki Kim; Young Kil Park; Hee Jin Kim
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464
View more
  5 in total

1.  Detection of Mixed Populations of Clarithromycin-Susceptible and -Resistant Mycobacterium abscessus Strains.

Authors:  Shamira J Shallom; Adrian M Zelazny
Journal:  J Clin Microbiol       Date:  2022-03-22       Impact factor: 11.677

2.  Predictive Performance of Pharmacokinetic Model-Based Virtual Trials of Vancomycin in Neonates: Mathematics Matches Clinical Observation.

Authors:  Bu-Fan Yao; Yue-E Wu; Bo-Hao Tang; Guo-Xiang Hao; Evelyne Jacqz-Aigrain; John van den Anker; Wei Zhao
Journal:  Clin Pharmacokinet       Date:  2022-05-06       Impact factor: 5.577

3.  Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates.

Authors:  Qi Guo; Jianhui Chen; Shaoyan Zhang; Yuzhen Zou; Yongjie Zhang; Dongdong Huang; Zhemin Zhang; Bing Li; Haiqing Chu
Journal:  Infect Drug Resist       Date:  2020-02-12       Impact factor: 4.003

4.  Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer.

Authors:  Fei Su; Ming Liu; Wei Zhang; Min Tang; Jinsong Zhang; Hexin Li; Lihui Zou; Rui Zhang; Yudong Liu; Lin Li; Jie Ma; Yaqun Zhang; Meng Chen; Fei Xiao
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

5.  MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection.

Authors:  Qi Guo; Yongjie Zhang; Junsheng Fan; Haonan Zhang; Zhemin Zhang; Bing Li; Haiqing Chu
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.